MSCDA forms task force to seek feedback from retailers for proposed online portal
|
Shardul Nautiyal, Mumbai
March 29 , 2017
|
|
The Maharashtra State Chemists and Druggists Association (MSCDA) has
formed a task force under the mentorship of its president Jagganath
Shinde to seek suggestions on health ministry proposed online
registration portal to ensure compliance through regulating sale of
drugs.
MSCDA has issued a letter to all its district presidents,
secretaries and office bearers seeking consultation on the same with
reference to regulation of sale of drugs in the country. The suggestions
should reach the MSCDA latest by 31 March, 2017 as per the letter. The
Health Ministry has sought recommendations from the stakeholders by
April 15, 2017.
As per the proposed plan, all the manufacturers,
stockists and retailers will be required to register themselves on the
e-portal and enter data related to sale of drugs with batch number,
quantity and expiry date. The data can be entered online through mobile
phones also as per the government’s notice.
As per the notice, no
retailer or e-pharmacy shall be permitted to sell any medicine/ drug
unless it is registered with the e-portal. They are supposed to enter
all the details of medicines and drugs sold, returned to the
manufacturer or disposed in any manner.
No sale by e-pharmacy
shall be permitted to be carried out by any person or entity unless it
has a licenced brick and mortar facility in each of the Licencing
Authority’s jurisdiction.
The notice further states that no
dispensing/sale of drugs shall be permitted by any entity beyond the
area for which a licence has been granted. Medicines other than drugs
included in Schedule H, H1 and X will be dispensed or made
available/distributed to any person only against prescription of a
registered medical practitioner. However, in case of a few identified
medicines, any other person specifically authorised (such as ASHA) to
distribute a particular class of medicines may do so.
The details
of medicines dispensed will be entered in the e-platform and bills will
be generated through the system. Such details will include prescribing
doctor’s registration number (MCI or State Medical Council or the Dental
Council of India) or other authorised person’s identity number, the
name and registration number of the dispensing chemist and the quantity
supplied, etc.
Details of other than the patient name and
identity shall not be necessary in case of drugs not included in
Schedule H, H-I or X.
The details of patient or authorised person
shall be kept confidential and shall not be disclosed to anyone other
than the Central and State Drug Regulators or other officers authorised
by the Central or State Governments. The details could, after removing
the confidential information, be also made available to the
Pharmacovigilance Programme of India (PvPI).
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|